AstraZeneca, AZN
Hosted on MSN20h
CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLCAstraZeneca AZN announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving its ...
AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...
The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...
Tagrisso has been recommended for approval in the European Union for the treatment of adult patients with locally advanced, ...
The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...
LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...
Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United ...
AstraZeneca (GB:AZN) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...
This combination drug is used to treat chronic obstructive pulmonary disease in adults, relieving symptoms and preventing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback